Roche Holding AG/Fr. RO
08:00
10:05
12:10
14:15
16:20
1D1W1MYTD1Y5YMAX
About Roche Holding AG
Roche Holding AG is a global healthcare company headquartered in Basel, Switzerland, operating primarily in the pharmaceuticals and diagnostics sectors. The company develops and manufactures innovative medicines and diagnostic tests with a focus on oncology, immunology, infectious diseases, ophthalmology, and neuroscience. Founded in 1896, Roche is known for pioneering personalized healthcare by combining pharmaceuticals and diagnostics. Its strategic positioning is strengthened by a robust R&D pipeline and significant investments in biotechnology. Roche operates worldwide, with a strong geographic presence in Europe, the Americas, and Asia-Pacific, enhancing its ability to meet diverse market needs.
Ticker
Fr. RO
Sector
Primary listing
XSWX
Employees
103,249
Headquarters
Basel, Switzerland
Website
Roche Holding AG Metrics
BasicAdvanced
CHF 256B
20.45
CHF 16.04
0.20
CHF 9.70
2.96%
Price and volume
Market cap
CHF 256B
Beta
0.2
52-week high
CHF 383.00
52-week low
CHF 244.00
Average daily volume
34K
Dividend rate
CHF 9.70
Financial strength
Current ratio
1.383
Quick ratio
1.048
Long term debt to equity
75.697
Total debt to equity
87.637
Dividend payout ratio (TTM)
60.02%
Interest coverage (TTM)
17.66%
Profitability
EBITDA (TTM)
24,044
Gross margin (TTM)
74.49%
Net profit margin (TTM)
20.33%
Operating margin (TTM)
33.08%
Effective tax rate (TTM)
18.70%
Revenue per employee (TTM)
CHF 610,000
Management effectiveness
Return on assets (TTM)
12.94%
Return on equity (TTM)
37.27%
Valuation
Price to earnings (TTM)
20.449
Price to revenue (TTM)
4.121
Price to book
7.58
Price to tangible book (TTM)
36.64
Price to free cash flow (TTM)
19.968
Free cash flow yield (TTM)
5.01%
Free cash flow per share (TTM)
16.426
Dividend yield (TTM)
2.96%
Forward dividend yield
2.96%
Growth
Revenue change (TTM)
1.54%
Earnings per share change (TTM)
55.58%
3-year revenue growth (CAGR)
-1.26%
10-year revenue growth (CAGR)
2.31%
3-year earnings per share growth (CAGR)
1.43%
10-year earnings per share growth (CAGR)
4.55%
3-year dividend per share growth (CAGR)
1.04%
10-year dividend per share growth (CAGR)
1.92%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Roche Holding AG stock?
Roche Holding AG (RO) has a market cap of Fr.256B as of March 16, 2026.
What is the P/E ratio for Roche Holding AG stock?
The price to earnings (P/E) ratio for Roche Holding AG (RO) stock is 20.45 as of March 16, 2026.
Does Roche Holding AG stock pay dividends?
Yes, the Roche Holding AG (RO) stock pays dividends to shareholders. As of March 16, 2026, the dividend rate is Fr.9.7 and the yield is 2.96%. Roche Holding AG has a payout ratio of 60.02% on a trailing twelve-month basis.
When is the next Roche Holding AG dividend payment date?
The next Roche Holding AG (RO) dividend payment is scheduled for March 16, 2026.
What is the beta indicator for Roche Holding AG?
Roche Holding AG (RO) has a beta rating of 0.2. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.